Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA IN RELATION TO TREATMENT WITH ANTIDEPRESSANTS - A SURVEYOF REPORTS IN THE WORLD-HEALTH-ORGANIZATION DATA-BASE FOR SPONTANEOUSREPORTING OF ADVERSE DRUG-REACTIONS, Pharmacotherapy, 17(2), 1997, pp. 348-352
Authors:
HEDENMALM K
SUNDGREN M
GRANBERG K
SPIGSET O
DAHLQVIST R
Citation: K. Hedenmalm et al., URINARY-EXCRETION OF CODEINE, ETHYLMORPHINE, AND THEIR METABOLITES - RELATION TO THE CYP2D6 ACTIVITY, Therapeutic drug monitoring, 19(6), 1997, pp. 643-649
Authors:
SPIGSET O
HEDENMALM K
DAHL ML
WIHOLM BE
DAHLQVIST R
Citation: O. Spigset et al., SEIZURES AND MYOCLONUS ASSOCIATED WITH ANTIDEPRESSANT TREATMENT - ASSESSMENT OF POTENTIAL RISK-FACTORS, INCLUDING CYP2D6 AND CYP2C19 POLYMORPHISMS, AND TREATMENT WITH CYP2D6 INHIBITORS, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 379-384
Citation: K. Hedenmalm et O. Spigset, PERIPHERAL SENSORY DISTURBANCES RELATED TO TREATMENT WITH FLUOROQUINOLONES, Journal of antimicrobial chemotherapy, 37(4), 1996, pp. 831-837
Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA DURING TREATMENT WITH CLOMIPRAMINE, PERPHENAZINE, OR CLOZAPINE - STUDY OF THERAPEUTIC DRUG-MONITORING SAMPLES, Journal of clinical psychopharmacology, 16(5), 1996, pp. 412-414
Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA AND THE SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION (SIADH) INDUCED BY PSYCHOTROPIC-DRUGS, Drug safety, 12(3), 1995, pp. 209-225